Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr390.10 DKK
Change Today +2.10 / 0.54%
Volume 2.7M
NOVOB On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
Mexico
Frankfurt
Frankfurt
As of 11:05 AM 05/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jerzy Gruhn

President of Novo Nordisk Inc, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mr. Jerzy Gruhn served as the President of Novo Nordisk Inc. until August 1, 2013. Mr. Gruhn served as a Senior Vice President of Biopharmaceuticals Research Unit - Novo Nordisk Denmark. He serves as a Member of Senior Management Board at Novo Nordisk A/S. He has worked in the biopharmaceutical sector for more than 20 years. During his 11 years with Novo Nordisk, he has played a critical role in the company's growth in Central and Eastern Europe, positively transforming ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr390.10 DKK +2.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.4M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
$500.0K
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.